SNCA and synucleinopathy: Furthermore, it has been shown that inoculation of animal models with distinct α-synuclein aggregates isolated from synucleinopathy patients with heterogeneous disease phenotypes induced likewise distinct α-synuclein neuropathologies [17, 34, 37].